Corporate News 07-Mar-19
Marksans Pharma's Goa facility concludes USFDA inspection with 8 observations
Marksans Pharma announced that U.S. FDA has concluded inspection of Company's Goa facility. The inspection of the facility took place between 25th February to 6th March 2019, resulting in a Form 483 with eight observations. None of these observations are considered either critical or repetitive in nature. Company is highly confident of closing these expeditiously and remains commited to global standards of quality & compliance. The site will continue to supply to the US markets all approved ANDA's. This inspection will help Company to receive pending ANDA's approval already filed by it.
Previous News
Marksans Pharma consolidated net profit rises 191.46% in the March 2023 quarter
( Results - Announcements 31-May-23 07:44 )
Marksans Pharma consolidated net profit rises 95.34% in the September 2020 quarter
( Results - Announcements 06-Nov-20 15:36 )
Marksans Pharma standalone net profit declines 53.52% in the September 2017 quarter
( Results - Announcements 13-Nov-17 15:59 )
Marksans Pharma standalone net profit rises 45.76% in the September 2022 quarter
( Results - Announcements 15-Nov-22 08:41 )
Board of Marksans allots 5.03 cr equity shares on conversion of warrants
( Corporate News - 20-Jan-23 10:01 )
Marksans Pharma receives upgrade in credit ratings
( Corporate News - 30-Jun-21 14:00 )
Marksans Pharma jumps after subsidiary receives market authorization for diarrhoea drug
( Hot Pursuit - 10-Dec-21 09:17 )
Marksans Pharma consolidated net profit rises 45.56% in the December 2018 quarter
( Results - Announcements 08-Feb-19 16:57 )
Marksans Pharma consolidated net profit rises 1285.29% in the September 2017 quarter
( Results - Announcements 13-Nov-17 17:00 )
Marksans Pharma jumps on raising funds via conversion of warrants
( Hot Pursuit - 20-Jan-23 11:03 )
Marksans Pharma to announce Quarterly Result
( Corporate News - 01-Aug-19 11:02 )
Other Stories
Share India Securities allots 16.92 lakh equity shares on conversion of warrants
06-Jul-24 13:11
Tinna Trade raises Rs 49 cr to fund its growth plans
06-Jul-24 11:10
Integra Essentia announces merger with G G Engineering
06-Jul-24 11:05
Ugro Capital to raise Rs 75 cr via NCD issuance
06-Jul-24 10:58
Board of D.P. Abhushan approves preferential allotment of shares and warrants
06-Jul-24 10:50
Life Insurance Corporation of India invest Rs 14 cr in Sri Lankan subsidiary
06-Jul-24 10:49
High Energy Batteries (India) to discuss results
06-Jul-24 10:29
Havells India schedules board meeting
06-Jul-24 10:29
Axis Bank announces board meeting date
06-Jul-24 10:29
Mastek to conduct board meeting
06-Jul-24 10:29
Back
Top
